The Gagnon Cardiovascular Institute at Morristown Medical Center (MMC) in Morristown, New Jersey, has now performed more than 4,000 transcatheter aortic valve replacement (TAVR) procedures, the hospital announced in Feb. 6. This includes more than 600 TAVR procedures in 2022 alone.
Back in 2011, MMC was the first hospital in New Jersey to offer TAVR as a treatment option for severe aortic stenosis. Now, more than a decade later, the hospital is home to one of the biggest TAVR programs in the United States. It received the American College of Cardiology's Transcatheter Valve Certification in 2021.
“Our team celebrates this milestone along with our patients as we continue to see evidence of successful outcomes for those who undergo TAVR procedures,” interventional cardiologist Philippe Genereux, MD, medical director of the Gagnon Cardiovascular Institute’s structural heart program, said in a prepared statement. “We are proud that we continue to play such a critical role in leading advancements in interventional cardiology and providing the highest level of cardiac care.”
In related news, Morristown Medical Center announced that Genereux was named one of Clarivate’s Highly Cited Researchers in the company’s 2022 rankings. This is his fourth year being included in the list.
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.